• Synergistic CDK4/6 and BET Inhibition Mitigates EMT in PDAC

  2026-06-02

  Gu et al. provide new mechanistic insight into pancreatic ductal adenocarcinoma (PDAC) by showing that combined CDK4/6 and BET inhibition not only suppresses tumor growth but also reverses EMT through modulation of the GSK3β-mediated Wnt/β-catenin pathway. This dual-targeted approach clarifies complex pathway crosstalk, offering a rationale for improved therapeutic strategies in aggressive malignancies.

• Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe): Technical

  2026-06-02

  Angiotensin II is an octapeptide vasopressor widely used in research models of hypertension, cardiovascular remodeling, and vascular smooth muscle cell hypertrophy. This guide details actionable parameters and troubleshooting for experimental design, highlighting where the peptide is best suited for mechanistic and preclinical studies—and clarifying storage, solubility, and workflow boundaries. It is not intended for diagnostic or clinical applications.

• Applied Use of Angiotensin 1/2 (5-7) in Renin-Angiotensin Re

  2026-06-01

  Angiotensin 1/2 (5-7) empowers cardiovascular and viral pathogenesis research with unmatched solubility, purity, and experimental flexibility. Discover protocol-driven insights, troubleshooting strategies, and the pivotal role of this H2N-Ile-His-Pro-OH peptide in dissecting renin-angiotensin signaling and SARS-CoV-2 interactions.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-01

  This study provides the first detailed analysis of sex-specific responses to Angiotensin II-induced hypertension in conscious mice, revealing that males develop more severe hypertension than females. The findings implicate sex hormones in modulating the hypertensive response and have direct implications for experimental design in cardiovascular research using Angiotensin II.

• ATF4-Regulated Enhancer Inhibition Suppresses Liver Fibrosis

  2026-05-31

  This study uncovers a non-canonical enhancer program driven by ATF4 in hepatic stellate cells that promotes liver fibrosis independently of classical ER stress. Targeting ATF4 translation presents a novel anti-fibrotic strategy and expands the mechanistic understanding of fibrosis beyond established stress response pathways.

• Optimizing Assays with EZ Cap™ Firefly Luciferase mRNA

  2026-05-30

  EZ Cap™ Firefly Luciferase mRNA streamlines sensitive gene regulation and in vivo imaging with its Cap 1 structure and optimized poly(A) tail. This article delivers actionable workflow tips, troubleshooting strategies, and leverages the latest research on buffer effects to maximize bioluminescent reporter performance.

• Angiotensin 1/2 (5-7): Translational Advances from RAS to Vi

  2026-05-29

  Explore how Angiotensin 1/2 (5-7) (H2N-Ile-His-Pro-OH) is redefining the frontier of renin-angiotensin system research and bridging cardiovascular and viral mechanistic domains. This thought-leadership article delivers evidence-backed strategic guidance for translational researchers, leveraging the latest peer-reviewed insights to inform experimental design and product selection.

• Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui

  2026-05-29

  The Superoxide Dismutase (SOD) Activity Assay Kit addresses the need for accurate, quantitative measurement of SOD enzyme activity in biological fluids, a critical parameter in oxidative stress research. It is suitable for research applications requiring colorimetric SOD detection but is not designed for diagnostic or clinical use.

• Hexa His Tag Peptide: Precision Tools for Protein Purificati

  2026-05-28

  Hexa His tag peptide enables antibody-free elution of His-tagged proteins, delivering unmatched purity in immunoprecipitation workflows. This guide bridges recent CARMIL membrane-binding insights with practical protocol optimization for advanced recombinant protein research.

• Topotecan HCl: Applied Protocols for Topoisomerase 1 Inhibit

  2026-05-28

  Topotecan HCl, a potent topoisomerase 1 inhibitor from APExBIO, excels in DNA damage and apoptosis studies across diverse tumor models. This guide delivers actionable workflows, advanced troubleshooting, and insights linking recent neuroinflammation research to translational oncology.

• Erastin in Advanced Prostate Cancer: A Precision Ferroptosis

  2026-05-27

  Explore how Erastin, a leading ferroptosis inducer, is redefining cancer biology research with a focus on advanced prostate cancer. This article delivers deep mechanistic insight, unique protocol guidance, and critical context for translational applications.

• Angiotensin 1/2 (5-7): Bridging Cardiovascular and Viral Res

  2026-05-27

  Explore the multifaceted research applications of Angiotensin 1/2 (5-7), a peptide central to both blood pressure regulation and SARS-CoV-2 binding mechanisms. This article uniquely dissects mechanistic insights and cross-domain protocols, offering advanced guidance for renin-angiotensin system research.

• Pazopanib Hydrochloride: Precision Tools for Oncology Assays

  2026-05-26

  Pazopanib Hydrochloride (GW786034) empowers researchers to dissect proliferation and cell death with unprecedented precision in cancer assay workflows. This article translates breakthrough in vitro methodologies into stepwise protocols, highlights troubleshooting strategies, and spotlights APExBIO’s trusted supply advantage.

• Angiotensin II in Translational Research: Mechanisms & Strat

  2026-05-26

  This thought-leadership article explores Angiotensin II’s mechanistic underpinnings in hypertension and cardiovascular remodeling, emphasizing its value as a research tool. Integrating the latest experimental findings—including the crosstalk between inflammation and fibrosis—it provides actionable guidance for translational researchers, protocol best practices, and a nuanced view of future directions. The discussion is anchored by evidence from primary literature and advanced workflow articles, transparently connecting molecular insights to strategic experimental design.

• Angiotensin II in Vascular Remodeling: Protocols and Insight

  2026-05-25

  Harness the power of Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) for precise modeling of hypertension, vascular smooth muscle cell hypertrophy, and abdominal aortic aneurysm. This article translates cutting-edge workflows and troubleshooting strategies for robust, reproducible cardiovascular research using APExBIO’s Angiotensin II.

7907 records 10/528 page Previous Next First page 上5页 678910 下5页 Last page